Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy

Figure 2

Kaplan–Meier curve for OS after CBA according to the risk group. We stratified the patients into two cohorts with low risk (0-1 risk factor) and high risk (2-3 risk factors). The median OS of patients in low and high risk were 14.2 months and 6.3 months.